key: cord-0761986-t3jx0812
authors: Díez-Manglano, Jesús; Solís-Marquínez, Marta Nataya; Álvarez García, Andrea; Alcalá-Rivera, Nicolás; Maderuelo Riesco, Irene; Gericó Aseguinolaza, Martín; Beato Pérez, José Luis; Méndez Bailón, Manuel; Labirua-Iturburu Ruiz, Ane-Elbire; García Gómez, Miriam; Martínez Cilleros, Carmen; Pesqueira Fontan, Paula María; Abella Vázquez, Lucy; Blázquez Encinar, Julio César; Boixeda, Ramon; Gil Sánchez, Ricardo; de la Peña Fernández, Andrés; Loureiro Amigo, José; Escobar Sevilla, Joaquín; Guzmán Garcia, Marcos; Martín Escalante, María Dolores; Magallanes Gamboa, Jeffrey Oskar; Martínez González, Ángel Luis; Lumbreras Bermejo, Carlos; Antón Santos, Juan Miguel
title: Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
date: 2021-02-19
journal: PLoS One
DOI: 10.1371/journal.pone.0247422
sha: 709fbc754ce5b56ccf1b245f581a07a3791d5fb6
doc_id: 761986
cord_uid: t3jx0812

AIM: To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19 have a worse prognosis than non-healthcare workers (NHCW). METHODS: Observational cohort study based on the SEMI-COVID-19 Registry, a nationwide registry that collects sociodemographic, clinical, laboratory, and treatment data on patients hospitalised with COVID-19 in Spain. Patients aged 20–65 years were selected. A multivariate logistic regression model was performed to identify factors associated with mortality. RESULTS: As of 22 May 2020, 4393 patients were included, of whom 419 (9.5%) were HCW. Median (interquartile range) age of HCW was 52 (15) years and 62.4% were women. Prevalence of comorbidities and severe radiological findings upon admission were less frequent in HCW. There were no difference in need of respiratory support and admission to intensive care unit, but occurrence of sepsis and in-hospital mortality was lower in HCW (1.7% vs. 3.9%; p = 0.024 and 0.7% vs. 4.8%; p<0.001 respectively). Age, male sex and comorbidity, were independently associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.211, 95%CI 0.067–0.667, p = 0.008). 30-days survival was higher in HCW (0.968 vs. 0.851 p<0.001). CONCLUSIONS: Hospitalized COVID-19 HCW had fewer comorbidities and a better prognosis than NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not carry more clinical severity nor mortality.

a1111111111 a1111111111 a1111111111 a1111111111 a1111111111

As of 30 October 2020, coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected 44,592,789 people worldwide [1] . Spain has been one of the countries with the highest number of confirmed cases and deaths.

Healthcare workers (HCW) are at high risk of infection with SARS-CoV-2 because of their exposure to infected patients. Several seroepidemiological studies have shown discordant results. In New York and Sweden the seroprevalence of SARS-CoV-2 among hospital HCW was high compared with the community [2, 3] . However, in Germany the seroprevalence in HCW was very low, 0.33% [4] . A recent systematic review and meta-analysis, that included 11 studies, reported that the overall proportion of HCW who were SARS-CoV-2 positive among all COVID-19 patients was 10.1% [5] . In Spain, 20.4% of confirmed COVID-19 cases were HCW [6] .

In Scotland, HCW and their households contributed a sixth of COVID-19 admissions to hospital [7] . In Spain and USA, 10% and 8% of HCW with COVID-19 were hospitalized respectively [6, 8] . Young women nurses were more frequently infected [9] [10] [11] . Comorbidities were frequent in HCW hospitalized with COVID-19, particularly diabetes, hypertension, obesity, asthma and immunodepression [6, 10, 11] .

There is still controversy over the risk of death in HCW with COVID-19. While it is high in Mexico, it is low in Germany and Malaysia [12, 13] . The main objectives of this study were to describe the clinical characteristics and outcomes of HCW hospitalised in Spain due to SARS--CoV-2 infection, and to determine if working in healthcare is associated with higher rates of complications and mortality.

The Sociedad Española de Medicina Interna-COVID-19 Registry (SEMI-COVID-19; SEMI is the acronym in English of Spanish Society of Internal Medicine) is an ongoing, nationwide, multicentre, observational retrospective registry, participated by 150 hospital centres throughout Spain. Detailed features of the registry have been reported elsewhere [14] [15] [16] . A total of 10,600 consecutive patients were recruited from March 1, 2020 to May 22, 2020.

The SEMI-COVID-19 Registry includes patients > 18 years admitted to hospital with COVID-19 confirmed microbiologically by reverse transcription polymerase chain reaction (RT-PCR) testing of a nasopharyngeal swab sample, sputum specimen or bronchoalveolar lavage. The exclusion criteria were subsequent admission of the same patient or denial or withdrawal of informed consent. This study analyses the subpopulation of patients between 20 and 65 years of age. In Spain, 20 years is the youngest possible age for working in healthcare and 65 years is the retirement age. HCW were defined as physicians, nurses, nurse aides, and nonhealthcare professionals such as the administrative and cleaning staff of hospitals and healthcare centres. In the workplace, all HCW were wearing personal protective equipment and had been educated about infection protection.

Admission and treatment of patients took place at the discretion of the attending physicians based on their clinical judgment, local protocols, and the updated recommendations of the Spanish Ministry of Health. The technical report of the Spanish Agency of Medicines and Medical Devices recommended lopinavir/ritonavir 400/100 mg bid, hydroxychloroquine 400 mg bid the first day and 200 mg bid after [17] . Other drugs as remdesivir, tocilizumab or interferon beta-1B were used in clinical trials or as compassionate use.

Data were collected retrospectively in an online electronic data capture system and were extracted from electronic health records. The access to database to obtain the data used in this study was on May 22th, 2020. Approximately 300 variables were collected including epidemiological data, RT-PCR data, personal medical and medication history, symptoms and physical examinations findings at admission, laboratory and diagnostic imaging tests, pharmacological treatment and ventilator support during hospitalization, complications and death during hospitalization, and readmissions and survival 30 days after diagnosis. Comorbidity was assessed using the Charlson Comorbidity Index (CCI) [18] . This index includes 19 diseases and each of them is assigned a weight from 1 to 6. A score of 0-1 is considered low comorbidity, 2 moderate comorbidity and � 3 high comorbidity. The Barthel index was used to measure ability to carry out basic daily living tasks in 10 areas: feeding, bathing, dressing, grooming, bladder control, bowel control, toilet use, transferring, moving on level surfaces, and walking up and downstairs [19] . Its scores range between 0 and 100: the higher the score the more independent the person. A patients is considered independent or mild dependent if his or her score is � 90, moderate dependent if is 60-90, and severe dependent if is <60. Obesity was defined as body mass index >30 kg/m 2 .

The main endpoint was mortality during admission. Intensive care unit (ICU) admission, days in the ICU, invasive or non-invasive ventilation, all-cause re-admission, 30-days all-cause mortality, and length-of-stay were secondary endpoints.

The study was carried out in accordance with the Declaration of Helsinki. The processing of personal data strictly complied with Spanish Law 14/2007, of July 3, on Biomedical Research and Spanish Organic Law 3/2018, of 5 December, on the Protection of Personal Data and the Guarantee of Digital Rights. The study was approved by the Provincial Research Ethics Committee of Málaga (Spain) following the recommendation of the Spanish Agency of Medicines and Medical Products (AEMPS, for its initials in Spanish). All patients-or their caregivers, in the event they presented with cognitive impairment-gave their informed oral consent. The consent was witnessed by the patient´s relatives and a nurse.

The patients were divided into two groups: HCW and non HCW (NHCW). Continuous variables were tested for normal distribution with the Kolmogorov-Smirnov test. Quantitative variables are expressed as mean (standard deviation, SD) or median [interquartile range]. Comparisons between groups were made using Student's t-test and the Mann-Whitney U test. Categorical variables are expressed as absolute frequencies and percentages. Comparisons between them were made using the chi-square test with the Yates correction and with the Fisher's exact test when necessary.

Two multivariate logistic regression models were performed to analyse the association between working in healthcare and occurrence of sepsis and mortality. The first model included age, sex, ethnicity, CCI score, and healthcare working. The second model included the previous variables and added the comorbidities with a statistical significance p<0.1 in the univariate model.

In all cases, statistical significance was established as p<0.05. Statistical analysis was carried out using Statistical Package for the Social Sciences (SPSS) 21.0 software for Windows.

Fig 1 shows the flowchart for patient inclusion. A total of 4,393 patients were included, of which 419 (9.5%) were HCW. Among HCW, 142 (33.9%) were medical doctors, 107 (25.5%) were nurses, 98 (23.4%) were nurse aides, and 72 (17.2%) held other positions within healthcare. The departments that most infected patients worked in were primary care (16.6%), the emergency department (11.3%), and internal medicine (11.3%). 

Baseline demographic and clinical characteristics and comorbidities are shown in Table 1 . HCW were more often Caucasian women, and reported more frequent contact with a COVID-19 patient (57.8% vs. 22.1%, p<0.001). HCW reported more frequently nosocomial infection (41.4% vs. 3.6%, p<0.001). Moderate and severe dependence was more frequent in NHCW. There was no difference in comorbidity measured as Charlson index score, but the prevalence of comorbidities as alcohol use disorder, hypertension, dyslipidemia, obesity, diabetes, myocardial infarction, stroke, dementia, chronic obstructive pulmonary disease, obstructive sleep apnea-hypopnea syndrome, chronic kidney disease and malignancy was higher in NHCW.

The median time from first symptoms to admission was 7 [5] [6] [7] [8] [9] days, without difference between HCW and NHCW. There were some differences in symptoms and physical examination findings. Dry cough (72.3% vs. 67.3%, p = 0.003), asthenia (54.6% vs. 44.8%, p<0.001), arthralgia (48.1% vs. 39.2%, p<0.001), ageusia (14.6% vs. 9.4%, p = 0.001) and anosmia (14.6% s. 8.7%, p<0.001) were more frequent in HCW, and temperature � 38˚C (74.4% vs. 68,5%, p = 0.007) and oxygen saturation � 92% (24.2% vs 11.8%, p<0.001) in NHCW.

At admission the levels of serum glucose, creatinine, urea, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, C-reactive protein, ferritin, D-dimer, hemoglobin and the count of white blood cells were lower in HCW. NHCW presented more frequently severe radiological findings-i.e. pleural effusion, bilateral condensation, and bilateral interstitial infiltrates (all p�0.025).

There were no differences in the treatment for COVID-19 disease between HCW and NHCW except for hydroxychloroquine and remdesivir (93% vs. 89.3%; p = 0.02 and 1.5% vs. 0.5%; p = 0.0.23 respectively). Table 2 shows the outcomes. Sepsis was more frequent in NHCW (3.9% vs. 1.7%; p = 0.024). Age, obesity, stroke and moderate-severe chronic kidney disease were associated with the occurrence of sepsis ( Table 3) . There were no differences in the occurrence of other complications, the need of respiratory support or ICU admission. The length of hospital stay was 8 (7) days without difference among HCW and NHCW.

During hospitalization 194 (4.4%) patients died. In-hospital mortality was lower in HCW (0.7% vs 4.8%; p<0.001). The readmission rate was 2.9%. Half of readmissions were due to COVID-19 disease ( Table 2 ). The 30-days survival was 96.8% in HCW and 85.1% in NHCW (p = 0.001). The factors associated with in-hospital mortality are shown in Table 4 . In the first multivariate analysis model, age, male sex and Charlson Comorbidity index score were associated with higher in-hospital mortality and healthcare working with lower mortality (OR 0.219, 95%CI 0.069-0.693, p = 0.01). In the second model, including comorbidities, healthcare working was also associated with a lower in-hospital mortality (OR 0.285 95%CI 0.089-0.908; p = 0.034).

The main findings of our study were that hospitalised HCW had less severe COVID-19 and lower mortality. The demographic characteristics of our patients were consistent with other reports [14, 20, 21] . Worldwide, men were more likely to be infected by SARS-CoV-2 than women. However, among HCW, women were the most affected [8, 9, 13, 22] . We think that this difference is due to the higher proportion of females in healthcare professions. When we compared our HCW cohort with those reported in other studies, our patients were more than ten years older [8-10, 13, 22, 23] . This could be due to the different inclusion criteria used in each study. In the USA, Hughes et al. [8] reported on the characteristics of 100,570 HCW with a median age of 41 years, of whom only 6832 were hospitalised. Wang et al included 80 HCW hospitalised in Wuhan, of whom 57 were confirmed cases and 23 were clinical diagnosis [11] . In our cohort, only hospitalised patients between 20 and 65 years old with a confirmed diagnosis of COVID-19 were included, while the rest included all HCW with COVID-19. An interesting finding in our study was that upon admission HCW presented milder symptoms, such as loss of smell or taste and arthralgia, less severe radiological findings and lower lactate dehydrogenase, C-reactive protein, serum ferritin and D-dimer levels. And all of it even though there was no difference between HCW and NHCW in time from onset of symptoms and admission. There was not an explanation for this, but we hypothesize that it could be due to HCW were hospitalised earlier and more easily than NHCW.

ARDS is overwhelmingly the main cause of death in hospitalised COVID-19 patients. In our study, sepsis was less frequent in HCW but there was no difference in ARDS, the rest of complications, the need of respiratory support nor the ICU admission. In-hospital and 30-days mortality were lower in HCW. In a systematic review Similar results were reported in the systematic review by Sahu et al. [5] . A healthy worker effect could explain these results. Severily ill and chronically disabled are ordinarily excluded from employment [24] . The difference observed in prevalence of comorbidities between HCW and NHCW supports this explanation. The better clinical and analytical profile of the HCW at admission may be due to their knowledge of mild symptoms of COVID-19 and their ability to identify them in themselves. In this regard, increased education on the earliest and mildest symptoms of COVID-19 could help NHCW to recognize and to report them to a healthcare centre earlier in the course of their disease.

There are geographical differences in mortality observed in hospitalised COVID-19 HCW. In a teaching hospital in Belgium the mortality of HCW was 0.5% [22] . In a single-centre study in Wuhan, in-hospital death in HCW with confirmed SARS-CoV-2 infection was 1.7%, more than twice in our study [11] . The mortality in a multicentre study in New York City was 21%, far higher than that we observed [21] . Also, high mortality, 14.7%, was reported in Brazil [10] . In Mexico, a mortality of 2% of HCW with COVID-19 was reported [23] . Their mortality was higher than ours even though only 9% of them needed to be hospitalized. The authors explain their high mortality because of different reasons. On the one hand, in Mexico there is a high prevalence of comorbidities which are associated with severe COVID-19. On the other hand, due to structural inequalities, their healthcare system is highly heterogeneous and there is a remarkable amount of marginalized communities. Therefore, the prevalence of comorbidities, the level of economic wealth, and the organization of healthcare in the different countries could explain these differences observed in the mortality. Several studies have reported that age, male sex and comorbidity were associated with higher mortality in COVID-19 patients [25] [26] [27] [28] . However the research about healthcare working as risk factor of mortality is scarce. HCW worry and are afraid to be infected and die for COVID-19. Our results confirm that COVID-19 is less severe and leads to less mortality in HCW. This is one of the novel contributions of our study that has evident clinical, epidemiological and occupational health implications.

Among the strengths of our study are its multicentre design, the inclusion of patients from the entire country, and the large number of patients included, which provides an adequate statistical power to confirm hypotheses. However, our study also has limitations. Only hospitalised patients were included, so it is not possible to extrapolate our results to non-hospitalised patients. The large number of researchers involved and variability in the availability of data in 

HCW had fewer comorbidities, milder symptoms, and a better prognosis than the NHCW. Our results suggest that professional exposure to COVID-19 in HCW does not lead to greater clinical severity nor mortality.

Project administration: Carlos Lumbreras Bermejo, Juan Miguel Antón Santos.

Validation: Jesús Díez-Manglano, Marta Nataya Solís-Marquínez.

Almería: Luis Felipe Díez García, Iris El Attar Acedo, Bárbara Hernandez Sierra, Carmen Mar Sánchez Cano

Hospital Alto Guadalquivir, Andújar: Begoña Cortés Rodríguez

Lugo: Raquel Gómez Méndez, Ana Rodríguez Á lvarez. Hospital San Pedro de Alcántara

Borja González López, María Soledad Hernández Garrido, Ana Isabel López Amorós, Maria de los Reyes Pascual Pérez

Formal analysis: Jesús Díez-Manglano, Marta Nataya Solís-Marquínez. Investigation: Jesús Díez-Manglano

References 1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Available from: https:// covid19.who.int/?gclid=EAIaIQobChMIjcGK1NDe6QIVWojVCh0vhQLLEAAYASABEgKs2fD_BwE. Last accessed

SARS-CoV-2 seroprevalence among health care workers in a New York city hospital: a cross-sectional analysis during the COVID-19 pandemic

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

A prospective sero-epidemiological evaluation of SARS-CoV-2 among health care workers in a German secondary care hospital

COVID-19 in health care workers-A systematic review and meta-analysis

Centro de Coordinació n de Alertas y Emergencias Sanitarias

Risk of hospital admission with coronavirus disease 2019 in healthcare workers and theirs households: nationwide linkage cohort study

Update: Characteristics of health care personnel with COVID-19-United States

Coronavirus disease 2019 (COVID-19) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China

Description of COVID-19 hospitalized health care worker cases in the first nine weeks of the pandemic, Brazil

Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan

High mortality among health personnel with COVID-19 in Mexico

COVID-19 among health workers in Germany and Malaysia

for the SEMI-COVID-19 Network. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network

Association of hypertension with all-cause mortality among hospitalized patients with COVID-19

for the SEMI-COVID-19 Network. Clinical characteristics and risk factors for mortality in very old patients hospitalized with COVID-19 in Spain

Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Functional evaluation: the Barthel Index

Clinical Characteristics of Coronavirus Disease 2019 in China

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium

Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes

A dictionary of epidemiology

Is older age associated with COVID-19 mortality in the absence of other risk factors? General population cohort study of 470,034 participants

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis